Literature DB >> 27542644

Management of Bone Sarcoma.

Christina J Gutowski1, Atrayee Basu-Mallick2, John A Abraham3.   

Abstract

Treatment of bone sarcoma requires careful planning and involvement of an experienced multidisciplinary team. Significant advancements in systemic therapy, radiation, and surgery in recent years have contributed to improved functional and survival outcomes for patients with these difficult tumors, and emerging technologies hold promise for further advancement.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone sarcoma; Chondrosarcoma; Endoprosthetic reconstruction; Ewing sarcoma; Osteosarcoma

Mesh：

Year:  2016        PMID： 27542644     DOI： 10.1016/j.suc.2016.06.002

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


  8 in total

1.  Bone Allograft Prosthesis Composite to Revise a Failed Massive Allo-Prosthesis: Case Report and 10 Years of Follow-Up.

Authors:  Manuel R Medellin; Alejandro Abiad; Vanessa Salinas; Luis Carlos Gomez-Mier; Camilo Soto Montoya
Journal:  Cureus       Date:  2020-12-19

2.  Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions.

Authors:  David Boyce-Fappiano; Ethan P Damron; Ahsan Farooqi; Devarati Mitra; Anthony P Conley; Neeta Somaiah; Dejka M Araujo; J Andrew Livingston; Ravin Ratan; Emily Z Keung; Christina L Roland; B Ashleigh Guadagnolo; Andrew J Bishop
Journal:  Adv Radiat Oncol       Date:  2022-02-05

3.  Near-infrared intraoperative imaging during resection of an anterior mediastinal soft tissue sarcoma.

Authors:  Jarrod D Predina; Andrew D Newton; Charuhas Desphande; Sunil Singhal
Journal:  Mol Clin Oncol       Date:  2017-11-08

4.  Using Machine Learning to Unravel the Value of Radiographic Features for the Classification of Bone Tumors.

Authors:  Derun Pan; Renyi Liu; Bowen Zheng; Jianxiang Yuan; Hui Zeng; Zilong He; Zhendong Luo; Genggeng Qin; Weiguo Chen
Journal:  Biomed Res Int       Date:  2021-03-11       Impact factor: 3.411

5.  Minichromosome maintenance protein 2 and 3 promote osteosarcoma progression via DHX9 and predict poor patient prognosis.

Authors:  Dong-Dong Cheng; Hui-Zhen Zhang; Jun-Qing Yuan; Shi-Jie Li; Qing-Cheng Yang; Cun-Yi Fan
Journal:  Oncotarget       Date:  2017-04-18

6.  TUFT1 Promotes Osteosarcoma Cell Proliferation and Predicts Poor Prognosis in Osteosarcoma Patients.

Authors:  Yao-Ping Yu; Jian-Guo He; Ping Li; Ning-Hui Qiu; Li-Jun Wang; Hui Feng
Journal:  Open Life Sci       Date:  2018-11-09       Impact factor: 0.938

7.  Antitumor activity of resveratrol against human osteosarcoma cells: a key role of Cx43 and Wnt/β-catenin signaling pathway.

Authors:  Da Xie; Gui-Zhou Zheng; Peng Xie; Qi-Hao Zhang; Fei-Xiang Lin; Bo Chang; Qin-Xiao Hu; Shi-Xin Du; Xue-Dong Li
Journal:  Oncotarget       Date:  2017-11-30

8.  Thirty-Day Outcomes after Surgery for Primary Sarcomas of the Extremities: An Analysis of the NSQIP Database.

Authors:  Kathryn E Gallaway; Junho Ahn; Alexandra K Callan
Journal:  J Oncol       Date:  2020-01-13       Impact factor: 4.375
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.